New possibilities of bioregulatory approach in therapy of cow mastitis
DOI:
https://doi.org/10.31548/dopovidi2022.01.014Keywords:
catarrhal mastitis, bioregulatory productsAbstract
Food security includes not only the mater of provision of basic foodstuffs to the population, but also the guarantee of their quality and safety for the consumer. These criteria are, especially, important for milk as the main food products. The pathological processes, which are developed in the breast, have negative effect on the quality of milk, and the medical products that are used in their treatment, may affect on the safety of this product.
In the article are represented the results of experimental research with the studying of an effectiveness of the bioregulatory approach in the treatment of catarrhal mastitis in cows with the use of medical products, which contain ultra-low doses of biologically active substances.
According to the results of the research was found, that the most effective is a combined scheme of treatment of mastitis, which includes the systemic antibiotic Ceftionel, intramuscular injection of Traumeel, intracisternal therapy of Lachesis compositum and local therapy of Traumeel( gel). These products haven’t a withdrawal period towards regarding milk.
On the 6th day of treatment of catarrhal mastitis recovered 100% of cows in this group, and an average duration of treatment was 5.1 days.
In the group of cows, which were treated with Ceftionel-50, the nonsteroidal anti-inflammatory product Ketoprosen, the syringe-tubes for intracisternal administration Mastamox and udder treatment with Sanofit ointment, only 40% of animals recovered on 6th day, and the mean duration of treatment for catarrhal mastitis was 7.8 days. Animals, which were treated, exclusively, with bioregulatory products for the treatment of catarrhal mastitis, an effectiveness of treatment was 57% on the 6th day, and an average period of complete recovery was 5.7 days.
So, the bioregulatory therapy in combination with the antibiotic Ceftionel provides synergistic action and high efficiency with correcting many pathogenetic mechanisms of the inflammatory response, as well as a high safety level of therapeutic measures.
References
Bala, S. S. (2010). Biologicheskie svojstva mikroflory, vydelennoj iz moloka korov s klinicheskoj i subklinicheskoj formami mastita [Biological properties of microflora isolated from milk of cows with clinical and subclinical forms of mastitis]. Izvestiya Orenburgskogo gosudarstvennogo agrarnogo universiteta, 4, (28-1), 287-289.
Valchuk, O., Stoliuk, V. (2010). Mastyty koriv, sprychyneni patohenamy bakterialnoi pryrody [Mastitis of cows caused by pathogens of bacterial nature]. Propozytsiia, 9, 118–121.
Karpenko, A. V. (2017). Upravlinnia yakistiu produktsii yak kliuchovyi faktor zabezpechennia konkurentospromozhnosti produktsii molokopererobnykh pidpryiemstv. [Product quality management as a key factor in ensuring the competitiveness of dairy products caused by pathogens of bacterial nature]. Ekonomika ta upravlinnia pidpryiemstvamy, 20, 345–350.
Kushnir, I. M. (2017). Problemy zakhvoriuvan molochnoi zalozy ta perspektyvy rozrobky novykh protymastytnykh preparativ [Problems of breast diseases and prospects for the development of new antimastitis drugs]. Naukovyi visnyk Lvivskoho natsionalnoho universytetu veterynarnoi medytsyny ta biotekhnolohii imeni S. Z. Hzhytskoho, 19 (82), 93-96.
Luchko, I. T. (2019). Vospalenie molochnoj zhelezy u korov (ehtiologiya, patogenez, diagnostika, lechenie i profilaktika) [Inflammation of the mammary gland in cows (etiology, pathogenesis, diagnosis, treatment and prevention)]. GGAU, 184.
Maslov, M. (2002). Lechenie mastitov bez stressov [Treatment of mastitis without stress]. Zhivotnovod dlya vsekh, 2, 40-45.
Murska, S. D. (2016). Suchasni naukovi pidkhody shchodo zabezpechennia yakosti moloka ta rozrobky bezpechnykh zasobiv bez antybiotykiv dlia likuvannia koriv khvorykh na mastyt [Modern scientific approaches to ensuring the quality of milk and the development of safe drugs without antibiotics for the treatment of cows with mastitis]. Naukovyi visnyk Lvivskoho natsionalnoho universytetu veterynarnoi medytsyny ta biotekhnolohii imeni S. Z. Gzhytskoho, 18 (1), 205–220.
Salina, A., Timenetsky, J., Barbosa, M., Azevedo, C., Langoni, H. (2020). Microbiological and molecular detection of Mycoplasma bovis in milk samples from bovine clinical mastitis. Pesquisa Veterinária Brasileira, 40(2), 82-87.
Downloads
Published
Issue
Section
License
Relationship between right holders and users shall be governed by the terms of the license Creative Commons Attribution – non-commercial – Distribution On Same Conditions 4.0 international (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
